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Abstract: The Myrtaceae family is a common source of medicines used in the treatment of 
numerous diseases in South America. In Brazil, fruits of the Campomanesia species are 
widely used to make liqueurs, juices and sweets, whereas leaves are traditionally employed 
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as a medicine for dysentery, stomach problems, diarrhea, cystitis and urethritis. Ethanol 
extracts of Campomanesia adamantium (Myrtaceae) leaves and fruits were evaluated against 
prostate cancer cells (PC-3). The compound (2E)-1-(2,4-dihydroxy-6-methoxyphenyl)-3-
phenylprop-2-en-1-one, cardamonin) was isolated from ethanol extracts of C. adamantium 
leaves in a bioactivity-guided study and quantified by UPLC-MS/MS. In vitro studies 
showed that the isolated chalcone cardamonin inhibited prostate cancer cell proliferation 
and decreased the expression of NFkB1. Moreover, analysis by flow cytometry showed 
that this compound induced DNA fragmentation, suggesting an effect on apoptosis 
induction in the PC-3 cell line. 
Keywords: Campomanesia adamantium; Myrtaceae; chalcone; cardamonin; apoptosis; 
cancer 
 
1. Introduction 
Application of natural products with therapeutic properties is as old as human civilization. Plants 
represent the largest sources of active substances that can be used in medical therapy due to the large 
structural diversity that these metabolites exhibit, being perhaps the oldest source of medicines for man [1]. 
Drugs derived from natural products with antibacterial, anticoagulant, antiparasitic, immunosuppressive 
and anticancer activity are capable of treating 87% of categorized human diseases [2]. Among the  
128 anticancer drugs released on the market between 1981 and 2010, 12 were natural products and  
32 were derived from natural products [3]. Such data justifies work in the area of natural products, 
particularly in view of its importance in the search for new drugs in cancer therapy. 
The Myrtaceae (121 genera, 3,800–5,800 spp) is one of the most important families in tropical 
forests. They consist of aromatic trees or shrubs, which frequently produce edible fruit. In the 
neotropics around 1,000 species of this family can be found. Several members are used in folk 
medicine, mainly as anti-diarrheic, antimicrobial, antioxidant, cleansing, antitumoral, anti-rheumatic, 
and anti-inflammatory agents, as well as to lower blood cholesterol. In addition, some fruits are eaten 
fresh or used to make juices, liqueurs and sweets very much appreciated by the population [4]. 
Campomanesia adamantium (Cambess.) O. Berg (Myrtaceae) is an edible fruit tree native to Brazil, 
very abundant in areas of the Cerrado in the Midwest region and the Atlantic Forest in the Southeast 
and South regions of Brazil [5]. In previous studies, the fruit extracts of C. adamantium collected in 
the Midwest of Brazil (State of Mato Grosso do Sul) were evaluated against the microorganism 
Mycobacterium tuberculosis. Ethyl acetate extracts and fractions have shown promising antibacterial 
activity [6] and extracts from the leaves of C. adamantium have been evaluated by the DPPH assay for 
antioxidant activity together with the isolation of five flavanones (7-hydroxy-5-methoxyflavanone,  
7-hydroxy-5-methyl-6-methoxyflavanone, 5,7-dihydroxy-6-methylflavanone, 5,7-dihydroxyflavanone and 
8-methyl 5,7-dihydroxy-6,8-dimethylflavanone) and four chalcones (2',4'-dihydroxy-6'-methoxy-chalcone, 
2',4'-dihydroxy-6'-methoxy-5'-methylchalcone, 2',4'-dihydroxy-6'-methoxy-3'-methylchalcone and  
2',6'-dihydroxy-4'-methoxy-3',5'-dimethylchalcone) [7]. Another specimen, growing in the South of Brazil, 
also showed antioxidant activity associated with the presence of chalcones and flavonoids, including 
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isoquercitrin, quercitrin, myricetin and quercetin [8]. Ethyl acetate and aqueous extracts from  
C. adamantium showed antinociceptive and anti-inflammatory activity in vivo and quercetin, myricitrin 
and myricetin were identified as possible compounds responsible for the anti-inflammatory activity, 
since such action was observed with these compounds in vitro [9]. Polyphenols have been identified in 
C. adamantium [8,9] and several studies have demonstrated antiproliferative activity involving this class 
of compounds [10,11]. Such data have encouraged the search for compounds with antiproliferative 
activity in C. adamantium. 
In this study, we evaluated the antiproliferative activities of extracts from fruits and leaves of  
C. adamantium in PC-3 prostate cancer cells as a part of a bioprospecting program for the discovery of 
antiproliferative agents against cancer cell lines in the Brazilian flora. The chalcone cardamonin was 
isolated through bioassay-guided fractionation and quantified in fruit and leaf extracts.  
The antiproliferative activity of cardamonin and its effect on apoptosis induction in PC-3 prostate 
cancer cells was also studied. 
2. Results and Discussion 
2.1. Extraction and Isolation 
From the crude ethanol extract of C. adamantium leaves we isolated the chalcone (2E)-1-(2,4-
dihydroxy-6-methoxyphenyl)-3-phenylprop-2-en-1-one), denominated cardamonin (Figure 1). The 1H and 
13C-NMR peaks were unambigously assigned by one-bond (HSQC) and long-range 1H-13C (HMBC) 
correlation experiments, and the molecular formula C16H14O4 was determined by MS ([M-H]− 269). 
All spectral data are in agreement with literature data [12]. 
2.2. Quantification by UPLC-MS 
UPLC–MS permitted the quantification of cardamonin concentrations in fruit and leaf extracts. 
Figure 1 shows chromatograms obtained from ethanol extracts of the fruits and leaves of C. adamantium. 
Quantification of the extract components highlighted cardamonin as the major compound. An average 
of 87.74 ± 1.07 μg/mg (mean ± standard deviation, analyzed in triplicate) was found in the leaf extract 
and 5.40 ± 13.07 μg/mg in the fruit extract. The linear fit was determined, with R2 = 0.99. 
2.3. Cardamonin, Fruit and Leaf Extracts Inhibited Survival of Cultured Human PC-3 Prostate 
Cancer Cells 
We studied the effects of fruit and leaf extracts and cardamonin on cell survival using human 
prostate cancer cell line PC-3 as a model, employing the sulforhodamine B assay to determine cell 
survival. This assay was used to determine the concentration necessary to inhibit 50% of growth 
(GI50) (Figure 2). The GI50 values for the leaf extracts, fruit extracts and cardamonin were 3.20, 14.25 
and 11.35 μg/mL, respectively, compared to 0.028 μg/mL for the positive control doxorubicin. These 
results show a direct relationship between antiproliferative activity of extracts from fruits and leaves of 
C. adamantium and concentration of cardamonin. Many studies with different tumor cell lines and 
animal models have suggested that some chalcones can inhibit tumor initiation, tumor progression and 
induction of apoptosis [10,11,13]. 
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Figure 1. Chemical structure of cardamonin and chromatographic profile of extracts from 
leaves and fruits of Campomanesia adamantium by UPLC/MS/MS in negative ion mode. 
(a) fruit extract; (b) leaf extract; (c); fruit extract + standard sample of cardamonin  
(d) leaf extract+ standard sample of cardamonin. 
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Figure 2. Antiproliferative activities in PC-3 cell line: (a) crude leaf extracts; (b) crude 
fruit extracts; (c) cardamonin and (d) doxorubicin after 48h treatment. G50: concentration 
necessary to inhibit 50% of growth; TGI: concentration necessary to inhibit 100% of 
growth and LC50 concentration necessary to be lethal 50% of cell line. 
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2.4. Cardamonin Decreases NF-kB1 Expression Measured by qRT-PCR in Cultured PC-3 Cells 
The NF-kB family consists of five proteins structurally related and functionally conserved: Rel A, 
Rel B, c-Rel, NFkB1 and NFkb2. The latter is a transcription factor that is activated in response to 
certain stimulations and plays a central role in the regulation of immune and inflammatory responses, 
apoptosis and oncogenesis [14,15]. It seems that NF-kB can convert inflammatory stimuli into tumor 
growth signals [16], suggesting it might be an important target for cancer therapy [14,15]. Cells treated 
with chalcone cardamonin and doxorubicin showed a decrease in gene expression NF-kB1 after 12, 24 
and 48 h of treatment when compared to control cells grown in the presence of a diluent (Figure 3). 
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Figure 3. Relative expression of NF-kB1 mRNA in PC-3 cells treated with cardamonin, 
measured by qRTPCR. Doxorubicin was used as a positive control. Values are the  
mean ± SD (n = 5). a = p < 0.05, ANOVA followed by the Tukey test, compared with the 
negative control at 12 h. b = p < 0.05, ANOVA followed by the Tukey test, compared with 
the negative control at 24 h. c = p < 0.05, ANOVA followed by the Tukey test, compared 
with the negative control at 48 h. 
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The decrease of NF-kB1 expression in cells treated with the chalcone was 69.63% after 12 h of 
treatment and 65.87% within 24 h of treatment compared to the control cells. Similarly, for cells 
treated with doxorubicin, a decrease in gene expression of NF-kB1 was observed, diminishing 61.26% 
in 12 h of treatment and 67.11% within 24 h of treatment in comparison with control cells. 
2.5. Flow Cytometric Analysis of DNA Fragmentation in Cultured Human PC-3 Prostate cancer Cells 
The final stage of apoptosis is characterized by degradation of DNA with formation of final 
fragments of 180–190 nucleotide pairs [17]. PC-3 cells treated with the isolated chalcone cardamonin 
and doxorubicin were analyzed for DNA fragmentation after treatment for 6, 12, 24 and 48 h and 
compared to cells treated with the diluent for 48 h (Figures 4 and 5). In cells treated for 6 h with 
cardamonin or with doxorubicin the percentage with fragmented DNA was 8.15% (±1.38) and 5.75% 
(±1.00), respectively. 
However the highest percentage of fragmentation was observed after 24 h of treatment with 15.09% 
(±3.96) for chalcone and 24.86% (±4.93) for doxorubicin. There was a significant increase in apoptosis 
(p < 0.05) at all treatment times examined when compared to cells treated with the diluent. After 24 h 
there was a decline in the percentage of cells undergoing apoptosis, possibly due to metabolic 
inactivation of the drug present in the medium. These data support the conclusion that cardamonin, like 
doxorubicin, induces cell death by apoptosis in PC-3 cells. 
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Figure 4. Percentage of PC-3cells with fragmented DNA as assessed by Flow Cytometry, 
indicating the end of the apoptosis process induced by treatment with the isolated 
cardamonin. Values are the mean ± SD (n = 5). * = p < 0.05, ANOVA followed by the 
Tukey test, compared with the negative control—cells cultived with diluent for 48 h. 
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Figure 5. Histogram representation of DNA fragmentation in PC-3 cells in flow cytometry. 
M1 region corresponds to cells with intact DNA and M2 region corresponds to cells with 
fragmented DNA: (a)—negative control, cells treated with diluent for 48 h; (b)—cells 
treated with doxorubicin for 48 h; (c)—cells treated with chalcone for 48 h; (d)—cells 
treated with doxorubicin for 24 h; (e)—cells treated with chalcone for 24 h; (f)—cells 
treated with doxorubicin for 12 h; (g)—cells treated with chalcone for 12 h; (h)—cells 
treated with doxorubicin for 6 h; (i)—cells treated with chalcone for 6 h. 
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Chalcones are intermediates in the biosynthesis of flavonoids and represent an important group of 
natural or synthetic compounds with an array of biological activities [18]. In cancer, several chalcones 
have been tested in vitro and some of them were cytotoxic [19]. In LNCaP prostate cancer cells, 
chalcones and dihydrochalcones were able to inhibit cell proliferation and induced apoptosis [20]. 
Antiproliferative activity studies with Syzygium samarangense (Myrtaceae) showed cytotoxic activity 
against the SW-480 human colon cancer cell line for natural chalcones, including cardamonin [21] and 
this compound suppresses the proliferation of colon cancer cells by promoting the degradation of 
intracellular β-catenin [22]. In another study it has been shown that cardamonin can block the nuclear 
factor-kappa B (NF-κB) pathway in multiple myeloma [23]. 
Although the cardamonim concentration necessary to inhibit 50% of growth of PC-3 cell lines is 
higher than that for doxorubicin, this fact would be irrelevant if the new drug can circumvent problems 
encountered in cancer therapy regarding the high incidence of adverse effects such as high toxicity of 
the anticancer drugs or even development of multidrug-resistance (MDR) of certain types of tumors. 
New drugs may interact with different receptors and can be useful in the treatment of tumors that have 
developed multidrug resistance through cell drug efflux mechanisms, alteration in target enzymes 
expression and synthesis, changes in drug degradation or activation pathways, as well as failure of the 
apoptotic processes [24–26]. 
3. Experimental 
3.1. General 
NMR spectra were recorded on a Bruker AC 200 spectrometer (Bruker, Charlotte, NC, USA), 
observing 1H at 200 and 13C at 50, respectively. The solvent used was CDCl3 + MeOH-D4, with TMS 
as internal reference. 
3.2. Plant Material 
Leaves of C. adamantium Camb. (Myrtaceae) were collected in September 2008 and fruits in 
January 2010 in Curitiba, Paraná State, Brazil, (25°26'35''S, 49°14'58''W), and identified by  
Dr. Armando C. Cervi. A voucher specimen (UPCB 60503) was deposited at the herbarium of the 
Universidade Federal do Paraná (UFPR), Brazil. 
3.3. Extraction and Isolation 
For isolation of the active compound, dried and powdered leaves (270.3 g) were extracted at room 
temperature with hexane, followed by EtOH (3 × 1 L for each solvent). Solvents were removed under 
reduced pressure to yield the crude extracts. The ethanol extract (20 g) was dissolved in 50% aqueous 
EtOH (300 mL) and partitioned successively with hexane, CH2Cl2 and 1-butanol, (3 × 100 mL of each 
solvent), yielding the respective fractions (hexane—5.3 g, CH2Cl2—2.9 g, BuOH—3.74 g).  
The CH2Cl2 fraction was submitted to silica gel VLC eluted sequentially with CH2Cl2, EtOAc and 
MeOH (300 mL, each solvent). The fraction eluted with EtOAc (0.95 g) was submitted to silica gel  
CC and eluted sequentially with mixtures of EtOAc-hexane (1:1, 2:1, 5:1, 100 mL each), mixtures of 
EtOAc–MeOH (4:1, 2:1, 1:5, (100 mL each) and finally pure MeOH (50 mL). After TLC analysis,  
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ten fractions were obtained. Fraction 2 (251.3 mg), eluted with EtOAc–hexane 1:1, was submitted to 
another CC, eluted with CH2Cl2, mixtures of CH2Cl2-MeOH (99:0.5, 99:1, 98:2, 50 mL each)  
and finally pure MeOH (20 mL) yielding seven subfractions after TLC analysis. The subfraction  
2.2 (24.4 mg) was submitted to preparative TLC, eluted with hexane-acetone 3:2 (twice) to give the 
final isolated single compound (17.6 mg). 50g of dried and powdered fruits were extracted at room 
temperature with EtOH (3 × 150 mL) and the solvent removed under reduced pressure to give the 
crude extract. The spectral data of the isolated substance was: 1H-NMR (200 MHz, CDCl3 + MeOH-D4) 
δH (mult (J in Hz); H): 3.92 (s; 3H, 6'-OCH3), 5.97 (d (2.2); 1H, H-5'), 6.01 (d (2.2); 1H, H-3'),  
7.41 (m; 3H, H-3, H-4 e H-5), 7.61 (m; 2H, H-2 e H-6), 7.75 (d (15,6); 1H, H-7), 7.91 (d (15.6); 1H, 
H-8). 13C-NMR (50 MHz, CDCl3 + MeOH-D4) δC: 135.4 (C-1), 128.2 (C-2 e C-6), 128.7 (C-3 and C-5), 
129.9 (C-4), 127.6 (C-8), 141.9 (C-7), 192.5 (C-9), 105.8 (C-1'), 1637.2 (C-2'), 96.1 (C-3'), 164.9 (C-4'), 
91.2 (C-5'), 163.2 (C-6'), 55.7 (6'-OCH3). 
3.4. UPLC-MS Quantification 
Concentrations of cardamonin in fruit and leaf extracts were analyzed on an Acquity UPLC system 
(Waters, Milford, MA, USA) using a UPLC column (2.1 × 50 mm, 1.7 μm particle size) at a 
temperature of 30 °C. A gradient of (A) deionized purified water with 1% formic acid and (B) 
methanol (Tedia, Brazil) starting with 10% B and ramping to 100% B at 5 min, holding to 5.50 min, 
then returning to initial conditions and re-equilibrating at 7 min. Detection in negative ion modes was 
achieved on an Acquity TQD mass spectrometer (Micromass Waters, Milford, MA, USA) with 
capillary voltage—3,000 V, Cone—30 V, source temperature 150 °C; desolvation temperature 350 °C. 
A calibration curve was established by plotting the peak area against concentrations of standards in the 
range 100 ng/mL and 100 μg/mL with linear regression analysis. The limit of detection (LD) was 
visually evaluated with a signal-to-noise ratio of about 3:1 and limit of quantification (LQ) was defined 
as the lowest concentration on the standard curve. Previously, the ion of interest was subjected to 
MS/MS analysis to make sure that the m/z corresponded to the same compound as the standard by 
direct insertion mass spectrometry with electrospray ionization in negative mode (ESI-MS/MS). 
3.5. Antiproliferative Assay 
A prostate tumor cell line (PC-3), from the American Type Culture Collection (ATCC, Manassas, 
VA, USA), was used for assays. Briefly, the cells were distributed in 96-well plates (100 μL/well) and 
exposed to various concentrations of isolated chalcone cardamonin (0.25, 2.5, 25.0 and 125.0 μg/mL) in 
DMSO (0.1%) at 37 °C, with 5% of CO2, for 48 h. The final concentration of DMSO did not affect the 
cell viability. A 50% trichloroacetic acid solution was added and, after incubation for 30 min at 4 °C, the 
cells were washed with water and dried. Cell proliferation was determined by spectrophotometric 
quantification (at 540 nm) of the cellular protein content using sulforhodamine B [27]. The experiments 
were carried out at least in triplicate. Using the concentration-response curve for each cell line,  
TGI (concentration that produces total growth inhibition or cytostatic effect) was determined through 
non-linear regression (sigmoidal fitting) analysis using the software ORIGIN 8.0 (OriginLab 
Corporation, Northampton, MA, USA) [28]. Doxorubicin was used as positive control. 
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3.6. Analysis of NF-kB1 Expression by qRT-PCR 
PC-3 cells were seeded in 6-well plates (105 cells/well) and subjected to treatment with cardamonin 
(20 µg/mL) and doxorubicin (20 µg/mL) for 12 and 24 h. Cells treated with the diluent RPMI/DMSO 
in the ratio 95:5 were used as negative control. In order to analyze the effects of treatment on the 
expression of NF-kB1, qRT-PCR reactions were performed for each well of PC-3 cell after 12 h and 24 h 
of incubation. Total RNA was extracted with TRIzol®, according to the manufacturer’s recommendations. 
Reverse transcription was performed with 1 µg of RNA using the SuperScript III (Invitrogen, 
according to manufacturer’s instructions) and quantitative RT-PCR was performed using a 7500 System 
(Applied Biosystems, Carlsbad, CA, USA). PCR conditions (20 μL reaction volume) were: 50 °C for  
2 min (1 cycle); 95 °C for 10 min (1 cycle); 95 °C for 15 s, 60 °C for 1 min (40 cycles).  
NF-kB1 primers were designed by Applied Biosystems (assay ID number: Hs00765730_m1) and 
endogenous control was GAPDH (VIC/MGB, Applied Biosystems). 
3.7. DNA Fragmentation Analysis by Flow Cytometry 
PC-3 cells were seeded in 6-well plates (105 cells/well) and subjected to treatment with isolated 
chalcone cardamonin (20 µg/mL) and doxorubicin (20 µg/mL) for 6, 12, 24 and 48 h. Cells treated 
with the diluent RPMI/DMSO in the ratio 95:5 were used as negative control. After these procedures, 
the cells were removed from the wells using a scraper, washed with buffer, and resuspended in 300 µL 
of hypotonic PI solution containing propidium iodide (50 mg/mL 0.1% sodium citrate and 0.1% Triton 
X-100). Samples were incubated overnight at 4 °C and analyzed by flow cytometry in a Facs Scalibur 
system (BD Bioscience, San Jose, CA, USA). The histograms of the samples were analyzed using the 
Cell Quest Pro software [29]. 
3.8. Statistical Analysis 
Data were expressed as means ± standard errors. Statistical significance of difference in measured 
variables between control and treated groups was determined by ANOVA followed by Tukey’s 
multiple comparison tests. Differences were considered significant at p < 0.05. 
4. Conclusions 
Based on our results, the compound cardamonin isolated from leaves of C. adamantium showed 
antiproliferative activity in the PC-3 cell line in a bioactivity-guided study, and induced apoptosis and 
downregulated the NFkB1 gene. Further studies investigating the role of the chalcone and  
C. adamantium natural products in biological systems are necessary to better define their therapeutic 
potential as a cytotoxic agent useful for possible in vivo applications in cancer treatment and 
prevention. Overall, our results may contribute to a comprehensive knowledge of the biological properties 
of C. adamantium, an edible fruit tree with medicinal properties native to Brazil, and furnish, at least in 
part, a scientific foundation to its popular use. 
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